We used the TaqMan probes to determine the genotypes of ABCA3 for the variants in 1,024 patients with ILD (the 30 sequenced subjects mentioned were not included), 109 patients with community acquired pneumonia and 1,054 healthy controls. This evidence concerns the gene ABCA3 and interstitial lung disease.